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Endophytes are microorganisms that reside asymptomatically in the tissues of higher plants and are a promising source of novel
organic natural metabolites exhibiting a variety of biological activities. The laboratory of Bioaromas (Unicamp, Brazil) develops
research in biotransformation processes and functional evaluation of natural products. With the intent to provide subsidies for
studies on endophytic microbes related to areas cited before, this paper focuses particularly on the role of endophytes on the
production of anticancer, antimicrobial, and antioxidant compounds and includes examples that illustrate their potential for
human use. It also describes biotransformation as an auspicious method to obtain novel bioactive compounds from microbes.
Biotransformation allows the production of regio- and stereoselective compounds under mild conditions that can be labeled as
“natural,” as discussed in this paper.
1.Introduction
The term “endophytes” includes a suite of microorganisms
that grow intra-and/or intercelullarly in the tissues of higher
plants without causing over symptoms on the plants in
which they live, and have proven to be rich sources of
bioactive natural products [1, 2]. Mutualism interaction
between endophytes and host plants may result in ﬁtness
beneﬁts for both partners [3]. The endophytes may provide
protection and survival conditions to their host plant by
producing a plethora of substances which, once isolated and
characterized, may also have potential for use in industry,
agriculture, and medicine [4, 5].
Approximately 300 000 plant species growing in unex-
plored area on the earth are host to one or more endo-
phytes [6], and the presence of biodiverse endophytes
in huge number plays an important role on ecosystems
with greatest biodiversity, for instance, the tropical and
temperate rainforests [5], which are extensively found in
Brazil and possess almost 20% of its biotechnological source
[7]. Considering that only a small amount of endophytes
have been studied, recently, several research groups have
been motivated to evaluate and elucidate the potential of
these microorganisms applied on biotechnological processes
focusing on the production of bioactive compounds.
The production of bioactive substances by endophytes
is directly related to the independent evolution of these
microorganisms, which may have incorporated genetic
information from higher plants, allowing them to better
adapt to plant host and carry out some functions such
as protection from pathogens, insects, and grazing animals
[6]. Endophytes are chemical synthesizer inside plants [8],
in other words, they play a role as a selection system for
microbes to produce bioactive substances with low toxicity
toward higher organisms [6].
Bioactive natural compounds produced by endophytes
have been promising potential usefulness in safety and
human health concerns, although there is still a signiﬁcant2 Biotechnology Research International
demand of drug industry for synthetic products due to
economicandtime-consumingreasons[4].Problemsrelated
to human health such as the development of drug resistance
in human pathogenic bacteria, fungal infections, and life
threatening virus claim for new therapeutic agents for
eﬀective treatment of diseases in human, plants, and animals
that are currently unmet [5, 6, 9].
RecentreviewbyNewmanandCragg[10]presentedalist
of all approved agents from 1981 to 2006, from which a sig-
niﬁcant number of natural drugs are produced by microbes
and/or endophytes. Endophytes provide a broad variety
of bioactive secondary metabolites with unique structure,
including alkaloids, benzopyranones, chinones, ﬂavonoids,
phenolic acids, quinones, steroids, terpenoids, tetralones,
xanthones, and others [2]. Such bioactive metabolites
ﬁnd wide-ranging application as agrochemicals, antibiotics,
immunosuppressants, antiparasitics, antioxidants, and anti-
cancer agents [11].
Methods to obtain bioactive compounds include the
extraction from a natural source, the microbial production
via fermentation, or microbial transformation. Extraction
from natural sources presents some disadvantages such as
dependency on seasonal, climatic and political features and
possible ecological problems involved with the extraction,
thus calling for innovative approaches to obtain such com-
pounds [12]. Hence, biotechnological techniques by using
diﬀerent microorganisms appear promising alternatives for
establishing an inexhaustible, cost-eﬀective and renewable
resource of high-value bioactive products and aroma com-
pounds. The biotransformation method has a huge number
of applications [13], for instance, it has been extensively
employed for the production of volatile compounds [12,
14, 15]. These volatile compounds possess not only sensory
properties, but other desirable properties such as antimi-
crobial (vanillin, essential oil constituents), antifungal and
antiviral (some alkanolides), antioxidant (eugenol, vanillin),
somatic fat reducing (nootkatone), blood pressure regulating
(2-[E]-hexenal), anti-inﬂammatory properties (1,8-cineole),
and others [16].
This paper focuses particularly on the role of endophytes
in the production of bioactive compounds, the importance
of including endophytic microbes in the screening approach
fornoveldrugs,andthemicrobialbiotransformationprocess
as a novel alternative method to obtain such compounds.
It also describes these compounds by diﬀerent functions,
including some examples that illustrate the potential for
humanuse.Finally,structuresofsomecompoundsproduced
by endophytes are shown in Figure 1.
2. Anticancer Compounds
Cancer is a group of diseases characterized by unregulated
growth and spread of abnormal cells, which can result in
death if not controlled [17]. It has been considered one of
the major causes of death worldwide: 7.4 million (about
13% of all deaths) in 2004 [18]. The anticancer drugs show
nonspeciﬁc toxicity to proliferating normal cells, possess
enormous side eﬀects, and are not eﬀective against many
forms of cancer [19, 20]. Thus, the cure of cancer has
beenenhancedmainlyduetodiagnosisimprovementswhich
allow earlier and more precise treatments [20].
There are some evidences that bioactive compounds
produced by endophytes could be alternative approaches for
discovery of novel drugs, since many natural products from
plants, microorganisms, and marine sources were identiﬁed
asanticanceragents[21].Theanticancerpropertiesofseveral
secondary metabolites from endophytes have been investi-
gated recently. Following, some examples of the potential
of endophytes on the production of anticancer agents are
cited.
The diterpenoid “Taxol” (also known in the literature
as paclitaxel) have generated more attention and interest
than any other new drug since its discovery, possibly due
to its unique mode of action compared to other anticancer
agents [19, 21]. This compound interferes with the mul-
tiplication of cancer cells, reducing or interrupting their
growth and spreading. FDA (Food and Drug Administra-
tion) has approved Taxol for the treatment of advanced
breast cancer, lung cancer, and refractory ovarian cancer
[22]. Taxol (C47H51NO14) was ﬁrstly isolated from the bark
of trees belonging to Taxus family (Taxus brevifolia), its
most common source [23]. Nevertheless, these trees are rare,
slow growing, and produce small amount of Taxol, which
explain its high price in the market when obtained by this
n a t u r a ls o u r c e[ 19]. Besides, in the context of environmental
degradation, the use of plant source as unique option have
limited the supply of this drug due to the destructive
collection of yew trees [24]. Several reports about Taxol
anticancer properties were published since its discovery [25–
27], as well as other sources for production of Taxol have
been investigated in the last decade.
The isolation of Taxol-producing endophyte Taxomyces
andreanae has provided an alternative approach to obtain
a cheaper and more available product via microorganism
fermentation [28]. After that, Taxol has also been found in
an u m b e ro fd i ﬀerent genera of fungal endophytes either
associated or not to yews, such as Taxodium distichum
[29]; Wollemia nobilis [30]; Phyllosticta spinarum [31];
Bartalinia robillardoides [19]; Pestalotiopsis terminaliae [32];
Botryodiplodia theobromae [33].
Another important anticancer compound is the alka-
loid “Camptothecin” (C20H16N2O4), a potent antineoplas-
tic agent which was ﬁrstly isolated from the wood of
Camptotheca acuminata Decaisne (Nyssaceae) in China
[34]. Camptothecin and 10-hydroxycamptothecin are two
important precursors for the synthesis of the clinically useful
anticancer drugs, topotecan, and irinotecan [35]. Although
its potential use in medical treatments, the unmodiﬁed
Camptothecin suﬀers from drawbacks that compromises its
applications due to very low solubility in aqueous media
and high toxicity [36, 37]. On the other hand, some Camp-
tothecin derivatives retain the medicinal properties and can
show other beneﬁts without causing over drawbacks in some
cases [38, 39]. Therefore, it is desirable to develop strategies
for isolation, mixture separation, and production of Camp-
tothecin and its analogues from novel endophytic fungal
sources. The anticancer properties of the microbial products
Camptothecin and two analogues (9-methoxycamptothecinBiotechnology Research International 3
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Figure 1: Some structures obtained from endophytics microorganisms.
and 10-hydroxycamptothecin) were already reported. The
products were obtained from the endophytic fungi Fusarium
solani isolated from Camptotheca acuminate [38]. Several
reports have described other Camptothecin (or analogues)
producing endophytes [40–44]. Since then, endophytes have
beenincludedinmanystudiespurposingnewapproachesfor
drug discovery.
“Ergoﬂavin” (C30H26O14), a dimeric xanthene linked
in position 2, belongs to the compound class called
ergochromes and was described as a novel anticancer agent4 Biotechnology Research International
isolatedfromanendophyticfungigrowingontheleavesofan
Indian medicinal plant Mimusops elengi (Sapotaceae) [45].
“Secalonic acid D” (C32H30O14), a mycotoxin also belonging
to ergochrome class, is known to have potent anticancer
activities. It was isolated from the mangrove endophytic
fungus and observed high cytotoxicity on HL60 and K562
cells by inducing leukemia cell apoptosis [46].
“Phenylpropanoids” have attracted much interest for
medicinal use as anticancer, antioxidant, antimicrobial,
anti-inﬂammatory, and immunosuppressive properties [47].
Despite the phenylpropanoids belong to the largest group of
secondary metabolites produced by plants, reports showed
the production of such compounds by endophytes. The
endophytic Penicillium brasilianum, found in root bark
of Melia azedarach, promoted the biosynthesis of phenyl-
propanoid amides [48]. Likewise, two monolignol gluco-
sides, coniferin and syringin, are produced not only by
the host plant, but were also recognized by the endophytic
Xylariaceae species as chemical signals during the estab-
lishment of fungus-plant interactions [49]. Koshino and
coworkers characterized two phenylpropanoids and lignan
from stromata of Epichloe typhina on Phleum pretense [50].
“Lignans” are other kinds of anticancer agents originated
as secondary metabolites through the shikimic acid path-
way and display diﬀerent biological activities that make
them interesting in several lines of research [51]. Although
their molecular backbone consists only of two phenyl-
propane units (C6-C3), lignans show enormous structural
and biological diversity, especially in cancer chemotherapy
[47].
“Podophyllotoxin” (C22H22O8) and analogs are clinically
relevant mainly due to their cytotoxicity and antiviral
activities and are valued as the precursor to useful anticancer
drugs like etoposide, teniposide, and etopophos phosphate
[52, 53]. The aryl tetralin lignans, such as podophyllotoxin,
arenaturallysynthesizedbyPodophyllum sps.,however,alter-
native sources have been searched to avoid endangered plant.
Another study showed a novel fungal endophyte, Trametes
hirsute, that produces podophyllotoxin and other related aryl
tetralin lignans with potent anticancer and properties [54].
Novel microbial sources of Podophyllotoxin were reported
from the endophytic fungi Aspergillus fumigatus Fresenius
isolated from Juniperus communis L. Horstmann [52],
Phialocephala fortinii isolated from Podophyllum peltatum
[55], and Fusarium oxysporum from Juniperus recurva [53].
Wagenaar and co-workers reported identiﬁcation of
three novel “cytochalasins”, bearing antitumor activity from
the endophyte Rhinocladiella sp. [56]. Extensive experiments
identiﬁed these new compounds as 22-oxa-12-cytochalasins.
“Torreyanic acid” (C38H44O12) is an unusual dimeric
quinone isolated from the endophytic fungus Pestalotiopsis
microspora from T. taxifolia (Florida torreya) and was proven
to have selective cytotoxicity 5 to 10 times more potent in
cell lines that are sensitive to protein kinase C agonists and
causes cell death by apoptosis [57]. “Gliocladicillins A” and
“ B ”w e r er e p o r t e da se ﬀective antitumor agents in vitro and
in vivo, since they induced tumor cell apoptosis and showed
signiﬁcant inhibition on proliferation of melanoma B16 cells
implanted into immunodeﬁcient mice [58].
C r u d eE x t r a c t so fAlternaria alternata,a ne n d o p h y t i c
fungus isolated from Coﬀea Arabica L., displayed moderate
cytotoxicactivitytowardsHeLacellsinvitro,whencompared
to the dimethyl sulfoxide-(DMSO-) treated cells [59]. The
investigation of endophytic actinomycetes associated with
pharmaceutical plants in rainforest reported 41 microor-
ganisms from the genus Streptomyces displayed signiﬁcant
antitumor activity against HL-60 cells, A549 cells, BEL-7404
cells, and P388D1 cells [1]. The screening of endophytic
fungi isolated from pharmaceutical plants in China showed
that 13.4% endophytes were cytotoxic on HL-60 cells and
6.4% on KB cells [60].
Finally, other compounds with anticancer properties
isolated from endophytic microbes were reported such as
“cytoskyrins” [61], “phomoxanthones A” and “B” [62],
“photinides A-F” [63], “rubrofusarin B” [64], and “(+)-
epiepoxydon” [65].
3. AntimicrobialCompounds
Metabolites bearing antibiotic activity can be deﬁned as
low-molecular-weight organic natural substances made by
microorganisms that are active at low concentrations against
other microorganisms [24]. Endophytes are believed to
carry out a resistance mechanism to overcome pathogenic
invasion by producing secondary metabolites [2]. So far,
studiesreportedalargenumberofantimicrobialcompounds
isolated from endophytes, belonging to several structural
classes like alkaloids, peptides, steroids, terpenoids, phenols,
quinines, and ﬂavonoids [66].
The discovery of novel antimicrobial metabolites from
endophytes is an important alternative to overcome the
increasing levels of drug resistance by plant and human
pathogens, the insuﬃcient number of eﬀective antibiotics
against diverse bacterial species, and few new antimicrobial
agents in development, probably due to relatively unfa-
vorable returns on investment [66, 67]. The antimicrobial
compounds can be used not only as drugs by humankind
but also as food preservatives in the control of food spoilage
and food-borne diseases, a serious concern in the world food
chain [68].
Many bioactive compounds, including antifungal agents,
have been isolated from the genus Xylaria residing in
diﬀerent plant hosts, such as “sordaricin” with antifungal
activity against Candida albicans [69]; “mellisol” and “1,8-
dihydroxynaphthol 1-O-a-glucopyranoside” with activity
against herpes simplex virus-type 1 [70]; “multiplolides A
and B” with activity against Candida albicans [71]. The
bioactive compound isolated from the culture extracts of the
endophytic fungus Xylaria sp. YX-28 isolated from Ginkgo
biloba L. was identiﬁed as “7-amino-4-methylcoumarin”
[68]. The compound presented broad-spectrum inhibitory
activity against several food-borne and food spoilage
microorganisms including S. aureus, E. coli, S. typhia, S.
typhimurium, S. enteritidis, A. hydrophila, Yersinia sp.,V .
anguillarum, Shigella sp., V. parahaemolyticus, C. albicans, P.
expansum, and A. niger, especially to A. hydrophila,a n dw a s
suggested to be used as natural preservative in food [68].Biotechnology Research International 5
Another strain F0010 of the endophytic fungus Xylaria
sp.f r o mAbies holophylla was characterized as a producer of
“griseofulvin” (C17H17ClO6), a spirobenzofuran antifungal
antibiotic agent used for the treatment of human and
veterinary animalsmycoticdiseases [72].Theyevaluatedand
reported high antifungal activity in vivo and in vitro of the
endophyte-produced griseofulvin against plant pathogenic
fungi,controllingeﬀectivelythedevelopmentofvariousfood
crops.
Aliphatic compounds, frequently detected in cultures of
endophytes, often show biological activities. Four antifungal
“aliphatic compounds” were characterized from stromata of
E. typhina on P. pratense [73]. Two novel ester metabolites
isolated from an endophyte of the eastern larch presented
antimicrobial activity. One compound was toxic to spruce
budworm (Choristoneura fumiferana Clem.) larvae, and the
other may serve as potent antibacterial agent against Vibrio
salmonicida, Pseudomonas aeruginosa, and Staphylococcus
aureus [74].
Chaetomugilin A and D with antifungal activities, were
isolated from an endophytic fungus C. globosum collected
from Ginkgo biloba [75]. Cytosporone B and C were isolated
from a mangrove endophytic fungus, Phomopsis sp. They
inhibited two fungi C. albicans and F. oxysporum with the
MIC value ranging from 32 to 64 mg·mL−1 [76].
Chlorinatedmetabolitessuchas(−)-mycorrhizinA,(+)-
cryptosporiopsin isolated from endophytic Pezicula strains
were reported as strongly fungicidal and herbicidal agents,
and to a lesser extent, as algicidal and antibacterial agents
[77]. Similarly, two other new chlorinated benzophenone
derivatives, “Pestalachlorides A” (C21H21Cl2NO5 and “B”
(C20H18Cl2O5), from the plantendophytic fungus Pestalo-
tiopsisadusta,proventodisplaysigniﬁcantantifungalactivity
against three plant pathogenic fungi, Fusarium culmorum,
Gibberella zeae, and Verticillium albo-atrum [78].
The production of “Hypericin” (C30H16O8), a naphtho-
dianthronederivative,and“Emodin”(C15H10O5)believ edto
bethemainprecursorofhypericin,bytheendophyticfungus
isolated from an Indian medicinal plant, was reported. Both
compounds demonstrated antimicrobial activity against
several bacteria and fungi, including Staphylococcus aureus
ssp. aureus, Klebsiella pneumoniae ssp. ozaenae, Pseudomonas
aeruginosa, Salmonella enterica ssp. Enteric, and Escherichia
coli, and fungal organisms Aspergillus niger and Candida
albicans [79].
An endophytic Streptomyces sp. from a fern-leaved
grevillea (Grevillea pteridifolia) in Australia was described as
a promising producer of novel antibiotics, “kakadumycin A”
and “echinomycin”. Kakadumycin A is structurally related
to echinomycin, a quinoxaline antibiotic, and presents
better bioactivity than echinomycin especially against Gram-
positive bacteria and impressive activity against the malarial
parasite Plasmodium falciparum [80].
More than 50% of endophytic fungi strains residing
in Quercus variabilis possessed growth inhibition against
at least one pathogenic fungi or bacteria. Cladosporium
sp., displaying the most active antifungal activity, was
investigated and found to produce a secondary metabolite
knownas“brefeldinA”(C16H24O4),alactonewithantibiotic
activity. Results showed brefeldin A to be more potent than
the positive control in antifungal activity [81].
“Coronamycin”, a peptide antibiotic produced by an
endophytic fungi Streptomyces sp. isolated from Monstera
sp., is active against pythiaceous fungi, the human fungal
pathogenCryptococcusneoformans,andthemalarialparasite,
Plasmodium falciparum [82]. Production of lipopeptide
“pumilacidin”, an antifungal compound, by B. pumilus
isolated from cassava cultivated by Brazilian Amazon Indian
tribes was described for the ﬁrst time [83]. The compounds
“2-hexyl-3-methyl-butanodioic acid” and “cytochalasin D”
were isolated from the endophytic fungus Xylaria sp. isolated
from Brazilian Cerrado, and presented antifungal activity
[84]. Two new bioactive metabolites, “ethyl 2,4-dihydroxy-
5,6-dimethylbenzoate”and“phomopsilactone”wereisolated
from an endophytic fungus Phomopsis cassiae from Cassia
spectabilis and displayed strong antifungal activity against
two phytopathogenic fungi, Cladosporium cladosporioides,
and C. sphaerospermum [85]. The polyketide “citrinin”,
produced by endophytic fungus Penicillium janthinellum
from fruits of Melia azedarach, presented 100% antibacterial
activity against Leishmania sp. [86].
Among the 12 secondary metabolites produced by the
endophytic fungi Aspergillus fumigatus CY018 isolated from
the leaf of Cynodon dactylon, “asperfumoid”, “fumigaclavine
C”, “fumitremorgin C”, “physcion”, and “helvolic acid”
were shown to inhibit Candida albicans [87]. Endophyte
Verticillium sp. isolated from roots of wild Rehmannia gluti-
nosa produced two compounds “2,6-Dihydroxy-2-methyl-7-
(prop-1E-enyl)-1-benzofuran-3(2H)-one”, reported for the
ﬁrst time, and “ergosterol peroxide” with clear inhibition of
thegrowthofthreepathogensincluding Verticilliumsp.[88].
An endophytic fungus Pestalotiopsis theae of an unidentiﬁed
tree on Jianfeng Mountain, China, was capable of producing
“Pestalotheol C” with anti-HIV properties [89].
Other secondary metabolites with antimicrobial proper-
ties isolated from endophytic microbes were reported like
“3-O-methylalaternin” and “altersolanol A” [90], “phomoe-
namide” [91], “phomodione” [92], “ambuic acid” [93],
“isopestacin” [6], and “munumbicin A, B, C” and “D” [94].
4. AntioxidantCompounds
The importance of compounds bearing antioxidant activ-
ity lays in the fact that they are highly eﬀective against
damage caused by reactive oxygen species (ROSs) and
oxygen-derived free radicals, which contribute to a vari-
ety of pathological eﬀects, for instance, DNA damages,
carcinogenesis, and cellular degeneration [95, 96]. Antiox-
idants have been considered promising therapy for pre-
vention and treatment of ROS-linked diseases as can-
cer, cardiovascular disease, atherosclerosis, hypertension,
ischemia/reperfusion injury, diabetes mellitus, neurode-
generative diseases (Alzheimer and Parkinson diseases),
rheumatoid arthritis, and ageing [97]. Many antioxidant
compounds possess anti-inﬂammatory, antiatherosclerotic,
antitumor, antimutagenic, anticarcinogenic, antibacterial, or
antiviral activities in higher or lower level [98–102].6 Biotechnology Research International
Natural antioxidants are commonly found in medic-
inal plants, vegetables, and fruits. However, it has been
reportedthatmetabolitesfromendophytescanbeapotential
source of novel natural antioxidants. Liu and coworkers
evaluated the antioxidant activity of an endophytic Xylaria
sp. isolated from the medicinal plant Ginkgo biloba [103].
The results collected indicated that the methanol extract
exhibited strong antioxidant capacity due to the presence
of “phenolics” and “ﬂavonoids” compounds among 41
identiﬁed compounds. Huang and coworkers investigated
the antioxidant capacities of endophytic fungal cultures of
medicinal Chinese plants and its correlation to their total
phenolic contents. They suggested that the phenolic content
were the major antioxidant constituents of the endophytes
[95].
“Pestacin” (C15H14O4) and “isopestacin”, 1,3-dihydro
isobenzofurans, were obtained from the endophytic fungus
Pestalotiopsis microspora isolated from a plant growing in
the Papua New Guinea, Terminalia morobensis [104, 105].
Besides antioxidant activity, pestacin and isopestacin also
presented antimycotic and antifungal activities, respectively.
Pestacin is believed to have antioxidant activity 11 times
greater than Trolox, a vitamin E derivative, primarily via
cleavage of an unusually reactive C-H bond and to a
lesser extent, O-H abstraction [104]. Isopestacin possess
antioxidant activity by scavenging both superoxide and
hydroxy free radicals in solution, added to the fact that
isopestacin is structurally similar to the ﬂavonoids [105].
Polysaccharides from plants and microorganisms have
been extensively studied and considered as potent natural
antioxidants [58, 106–109]. Liu and coworkers reported,
for the ﬁrst time, the capacity of endophytic microor-
ganisms to produce polysaccharides with antioxidant. The
bacterium endophyte Paenibacillus polymyxa isolated from
the root tissue of Stemona japonica Miquel, a traditional
Chinese medicine, produced “exopolysaccharides (EPS)”
thatdemonstratedstrongscavengingactivitiesonsuperoxide
and hydroxyl radicals [110].
“Graphislactone A”, a phenolic metabolite isolated from
theendophyticfungusCephalosporiumsp.IFB-E001residing
in Trachelospermum jasminoides, demonstrated to have free
radical-scavengingandantioxidantactivitiesinvitrostronger
than the standards, butylated hydroxytoluene (BHT) and
ascorbic acid, coassayed in the study [111].
For more detailed information on antimicrobial, antiox-
idant, and anticancer agents from microbial source, the
references Newman and Cragg [10]a n dF i r ´ akov´ aa n d
coworkers [21] are recommended.
5. Biotransformation Process
Biotransformation can be deﬁned as the use of biological
systems to produce chemical changes on compounds that
are not their natural substrates [112]. The microbial growth,
sustenance, and reproduction depends on the availability of
a suitable form of reduced carbon source, used as chemical
energy, which under normal conditions of culture broth
are the common sugars. Nevertheless, microorganisms are
believed to have no limit to adapt to new environments
and to metabolize various foreign substrates to carbon and
nitrogensources[113].Amoleculecanbemodiﬁedbytrans-
forming functional groups, with or without degradation of
carbon skeleton. Such modiﬁcations result in the formation
of novel and useful products not easily prepared by chemical
methods [13].
The biotransformation process provides a number of
advantages over chemical synthesis. The process can be car-
riedoutundermildconditionslikeambienttemperatureand
without the need of high pressure and extreme conditions,
thus reducing undesired byproduct, energy needs, and cost
[114]. The region-and stereo-selectivity of the process allows
the production of enantiomerically pure compounds, elimi-
nating the need for complicated separation and puriﬁcation
steps [112, 115]. Besides, the reactions occur under ecologi-
cally acceptable conditions, with lower emission of industrial
resides and production of biodegradable resides and prod-
ucts, thus reducing the environmental problems [12, 116].
Finally, the products obtained by biotransformation process
can be labeled as “natural.” On the other hand, chemical syn-
thesis often result in environmentally unfriendly production
processes and lacks substrate selectivity, possibly causing the
formation of undesirable reaction mixtures, and reducing
process eﬃciency and increasing downstream cost [117].
Therefore, biotransformation is a useful method for
production of novel compounds; enhancement in the pro-
ductivity of a desired compound; overcoming the prob-
lems associated with chemical analysis; leading to basic
information to elucidate the biosynthetic pathway [114].
For this reason, biotransformation using microbial cultures
and/or their enzymatic systems alone has received increasing
attention as a method for the conversion of lipids, monoter-
penes, diterpenes, steroids, triterpenes, alkaloids, lignans,
and some synthetic chemicals, carrying out stereospeciﬁc
and stereoselective reactions for the production of novel
bioactive molecules with some potential for pharmaceutical
and food industries [13, 118].
Endophytic microorganisms are able to produce neces-
sary enzymes for the colonization of plant tissues, and to
use, at least in vitro, most plant nutrients and components
[21]. Therefore, more recently, endophytes have received
attention as biocatalysts in the chemical transformation of
natural products and drugs, due to their ability to modify
chemical structures with a high degree of stereospeciﬁcity
and to produce known or novel enzymes that facilitates the
production of compounds of interest. Although the high
potential of these microorganisms, studies using endophytes
in the ﬁeld of biotransformation are still limited.
The biotransformation of a tetrahydrofuran lignan,
(−)-grandisin, by the endophytic fungus Phomopsis
sp. from Viguiera arenaria was demonstrated by Verza
and coworkers [119]. The process led to the formation
of a new compound named as “3,4-dimethyl-2- (4 -
hydroxy-3 ,5  -dimethoxyphenyl)-5-methoxy-tetrahydro-
furan”, which showed trypanocidal activity similar to its
natural corresponding precursor against the causative
agent of Chagas disease, the parasite Trypanosoma cruzi.
Zikmundov´ a and coworkers reported an endophytic fungus
isolated from the roots and shoots of Aphelandra tetragona,Biotechnology Research International 7
capable to transform benzoxazinones, 2-benzoxazolinone
(BOA) and 2-hydroxy-1,4-benzoxazin-3-one (HBOA), into
diﬀerent series of compounds [120].
The use of endophytic fungi in the stereoselective kinetic
biotransformation of “thioridazine (THD)”, a phenothiazine
neuroleptic drug, was investigated. Results showed that
these microorganisms are able to biomimic mammalian
metabolism via biotransformation reactions [112]. Another
studyemployedendophyticfungusonthebiotransformation
of“propranolol(Prop)”toobtain4-OH-Propactivemetabo-
lite in enantiomerically pure form [13].
Another interesting topic in biotransformation process is
the use of endophytes in the biotransformation of terpenes
for production of novel compounds through enzymatic
reactions carried out by these microbes. “Terpenes” are
large class of bioactive secondary metabolites used in the
fragrance and ﬂavor industries, and have been extensively
used in biotransformation process by microorganisms with
focus on the discovery of novel ﬂavor compounds and on
the optimization of the process condition [12]. Microbial
transformationsofterpeneswerepublishedrecentlyusing R-
(+)-limonene [14, 121], L-menthol [122], α-a n dβ-pinene
[123,124],andα-farnesene[15],bydiversemicroorganisms.
However,someresearchgroupshavealsoinvestigatedstudies
with the biotransformation of terpenes by endophytes.
Other endophytic microbes were studied for the capa-
bility to biotransform natural products like taxoids [125],
alkaloids [126], pigment curcumim [127], betulinic, and
betulonic acids [128].
6. Conclusion
Endophytes have proven to be rich sources of novel natural
compoundswithawide-spectrumofbiologicalactivitiesand
a high level of structural diversity. The use of endophytes
as biocatalysts in the biotransformation process of natural
products assumes greater importance. However, the appli-
cation of microorganisms by the food and pharmaceutical
industries to obtain compounds of interest is still modest,
considering the great availability of useful microorganisms
and the large scope of reactions that can be accomplished by
them.
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